Rates of visual field progression in clinical glaucoma care

Acta Ophthalmologica

Volumn 91, Issue 5, 2013, Pages 406-412

  Heijl, Anders ^a   Buchholz, Patricia ^b   Norrgren, Gunilla ^c   Bengtsson, Boel ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Regional Council Karlsruhe   (Germany)

^c ALLERGAN PLC   (United States)

Author keywords

Glaucoma; progression; rate of progression; visual field

Indexed keywords

ADULT; AGED; ARTICLE; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OPEN ANGLE GLAUCOMA; PERIMETRY; PRIORITY JOURNAL; PSEUDOEXFOLIATION; PSEUDOEXFOLIATION GLAUCOMA; TREATMENT OUTCOME; VISUAL FIELD; VISUAL FIELD DEFECT;

GLAUCOMA; PROGRESSION; RATE OF PROGRESSION; VISUAL FIELD;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; EXFOLIATION SYNDROME; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; MALE; MIDDLE AGED; MORBIDITY; RETROSPECTIVE STUDIES; RISK FACTORS; SCOTOMA; SWEDEN; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 84880272786     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2012.02492.x     Document Type: Article

References (35)

1. Ahrlich KD, de Moraes CG, Teng CC, Prata TS, Tello C, Ritch R, &, Liebmann JM, (2010): Visual field progression differences between normal-tension and exfoliative high-tension glaucoma. Invest Ophthalmol Vis Sci 51: 1458-1463.
2. Anderson DR, Drance SM, &, Schulzer M, (2001): Natural history of normal-tension glaucoma. Ophthalmology 108: 247-253.
3. Bengtsson B, Olsson J, Heijl A, &, Rootzen H, (1997): A new generation of algorithms for computerized threshold perimetry, SITA. Acta Ophthalmol Scand 75: 368-375.
4. Bengtsson B, Leske MC, Hyman L, &, Heijl A, (2007): Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology 114: 205-209.
5. Caprioli J, &, Coleman AL, (2008): Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study. Ophthalmology 115: 1123-1129 e1123.
6. Chauhan BC, Mikelberg FS, Balaszi AG, LeBlanc RP, Lesk MR, &, Trope GE, (2008): Canadian Glaucoma Study: 2. risk factors for the progression of open-angle glaucoma. Arch Ophthalmol 126: 1030-1036.
7. Chauhan BC, Mikelberg FS, Artes PH, Balazsi AG, LeBlanc RP, Lesk MR, Nicolela MT, &, Trope GE, (2010): Canadian glaucoma study: 3. Impact of risk factors and intraocular pressure reduction on the rates of visual field change. Arch Ophthalmol 128: 1249-1255.
8. Collaborative Normal-Tension Glaucoma Study Group (1998): The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 126: 498-505.
9. De Moraes CG, Juthani VJ, Liebmann JM, Teng CC, Tello C, Susanna R, &, Ritch R, (2011): Risk factors for visual field progression in treated glaucoma patients. Arch Ophthalmol 129: 562-568.
10. Eid TM, Spaeth GL, Bitterman A, &, Steinmann WC, (2003): Rate and amount of visual loss in 102 patients with open-angle glaucoma followed up for at least 15 years. Ophthalmology 110: 900-907.
11. European Glaucoma Society (2008): Terminology and guidelines for glaucoma. Savona: Editrice Dogam S.r.l.
12. Forchheimer I, de Moraes CG, Teng CC, Folgar F, Tello C, Ritch R, &, Liebmann JM, (2011): Baseline mean deviation and rates of visual field change in treated glaucoma patients. Eye 25: 626-632.
13. Gliklich RE, Steinmann WC, &, Spaeth GL, (1989): Visual field change in low-tension glaucoma over a five-year follow-up. Ophthalmology 96: 316-320.
14. Gordon MO, Beiser JA, Brandt JD, et al., (2002): The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120: 714-720; discussion 829-730.
15. Grødum K, Heijl A, &, Bengtsson B, (2002): A comparison of glaucoma patients identified through mass screening and in routine clinical practice. Acta Ophthalmol Scand 805: 627-631.
16. Heijl A, Bengtsson B, &, Patella VM, (2000): Glaucoma follow-up when converting from long to short perimetric threshold tests. Arch Ophthalmol 118: 489-493.
17. Heijl A, Bengtsson B, Hyman L, &, Leske MC, (2009): Natural history of open-angle glaucoma. Ophthalmology 116: 2271-2276.
18. Heijl A, Alm A, Bengtsson B, Bergström A, Calissendorff B, Lindblom B, &, Lindén C, (2010): Riktlinjer för glaukomsjukvården. Malmö: Sveriges Ögonläkarförening, Bäcklunds Media.
19. Kobelt-Nguyen G, Gerdtham UG, &, Alm A, (1998): Costs of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observational two-year chart review of newly diagnosed patients in Sweden and the United States. J Glaucoma 7: 95-104.
20. Leske MC, Heijl A, Hyman L, &, Bengtsson B, (1999): Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology 106: 2144-2153.
21. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, &, Komaroff E, (2003): Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 121: 48-56.
22. Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, &, Yang Z, (2007): Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 114: 1965-1972.
23. Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA, &, Mills RP, (2001): Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 108: 1943-1953.
24. Lindblom B, Nordmann JP, Sellem E, et al., (2006): A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden. Acta Ophthalmol Scand 84: 74-83.
25. Membrey WL, Poinoosawmy DP, Bunce C, Fitzke FW, &, Hitchings RA, (2000): Comparison of visual field progression in patients with normal pressure glaucoma between eyes with and without visual field loss that threatens fixation. Br J Ophthalmol 84: 1154-1158.
26. Miglior S, Pfeiffer N, Torri V, Zeyen T, Cunha-Vaz J, &, Adamsons I, (2007): Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology 114: 3-9.
27. Mills RP, Budenz DL, Lee PP, Noecker RJ, Walt JG, Siegartel LR, Evans SJ, &, Doyle JJ, (2006): Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease. Am J Ophthalmol 141: 24-30.
28. Nouri-Mahdavi K, Hoffman D, Coleman AL, Liu G, Li G, Gaasterland D, &, Caprioli J, (2004): Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 111: 1627-1635.
29. Oostenbrink JB, Rutten-van Molken MP, &, Sluyter-Opdenoordt TS, (2001): Resource use and costs of patients with glaucoma or ocular hypertension: a one-year study based on retrospective chart review in the Netherlands. J Glaucoma 10: 184-191.
30. Ritch R, (2001): Exfoliation syndrome. Curr Opin Ophthalmol 12: 124-130.
31. Ritch R, &, Schlotzer-Schrehardt U, (2001): Exfoliation syndrome. Surv Ophthalmol 45: 265-315.
32. Singh K, &, Shrivastava A, (2009): Intraocular pressure fluctuations: how much do they matter? Curr Opin Ophthalmol 20: 84-87.
33. The AGIS Investigators (2000): The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130: 429-440.
34. The AGIS Investigators (2002): The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol 134: 499-512.
35. Zahari M, Mukesh BN, Rait JL, Taylor HR, &, McCarty CA, (2006): Progression of visual field loss in open angle glaucoma in the Melbourne Visual Impairment Project. Clin Experiment Ophthalmol 34: 20-26.